Evidence map›Paper›PMID 33472525›Full record

ArticlePrion2021

System degeneration in an MM1-type sporadic Creutzfeldt-Jakob disease case with an unusually prolonged akinetic mutism state.

Yasushi Iwasaki, Keiko Mori, Masumi Ito, Yoshinari Kawai, Akio Akagi, Yuichi Riku, Hiroaki Miyahara, Atsushi Kobayashi, Tetsuyuki Kitamoto, Mari Yoshida

Open access · goldAbstract readCase Reports
In one paragraph

Article in Prion, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yasushi IwasakiDepartment of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University , Nagakute, Japan.ORCID 0000-0002-0059-3104
Keiko MoriDepartment of Neurology, Oyamada Memorial Spa Hospital , Yokkaichi, Japan.
Masumi ItoDepartment of Neurology, Oyamada Memorial Spa Hospital , Yokkaichi, Japan.
Yoshinari KawaiDepartment of Neurology, Oyamada Memorial Spa Hospital , Yokkaichi, Japan.
Akio AkagiDepartment of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University , Nagakute, Japan.
Yuichi RikuDepartment of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University , Nagakute, Japan.
Hiroaki MiyaharaDepartment of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University , Nagakute, Japan.
Atsushi KobayashiLaboratory of Comparative Pathology, Faculty of Veterinary Medicine, Hokkaido University , Sapporo, Japan.
Tetsuyuki KitamotoDepartment of Neurological Science, Tohoku University Graduate School of Medicine , Sendai, Japan.
Mari YoshidaDepartment of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University , Nagakute, Japan.
Aichi Medical University · JPHokkaido University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methionine/methionine type 1 (MM1-type) sporadic Creutzfeldt-Jakob disease (sCJD), known as the 'classic type,' shows typical clinicopathological sCJD findings. In general, patients reach an akinetic mutism state within a few months of disease onset and die soon after if supportive therapies are not administered. Here, we describe remarkable neuropathologic observations of MM1-type sCJD in a 48-year-old, Japanese man with an unusually prolonged akinetic mutism state. In the early disease stages, the patient exhibited abnormal behaviour with gait disturbance and rapidly progressive cognitive dysfunction. Diffusion-weighted magnetic resonance imaging revealed extensive cerebral cortical hyperintensity. Prion protein (PrP) gene analysis revealed no mutations, and the polymorphic codon 129 exhibited methionine homozygosity. Although the patient remained stable with tube feeding for more than 2 years after reaching the akinetic mutism state, he died because of central respiratory failure 30 months after disease onset. Neuropathologic investigation showed extensive devastating lesions, such as status spongiosus, and typical spongiform changes could no longer be observed in the cerebral neocortex. Conspicuous pyramidal tract degeneration was observed. However, the regions commonly preserved in MM1-type sCJD pathology were still relatively preserved. Immunostaining revealed extensive diffuse synaptic-type PrP deposition in the grey matter. The pathological findings suggested that sCJD is a neurodegenerative disease that shows system degeneration; there are primary and secondary degenerative regions and distinct preserved regions, even in cases with prolonged disease duration. In addition, it is considered that there is a limited survival period for MM1-type sCJD, even if active symptomatic treatment is provided.

Indexed as

Akinetic MutismCreutzfeldt-Jakob SyndromeNeurodegenerative DiseasesHumansMaleMethionineMiddle AgedPrion ProteinsMethioninePrion Proteinsakinetic mutism stateCreutzfeldt-Jakob diseasepanencephalopathic-typepyramidal tract degenerationsystem degeneration

Identifiers

PMID33472525
PMCPMC7833778
OpenAlexW3124644880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.